Ping-Hsuan Tsai
6PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 08, 2025
Long-Term Pentoxifylline Therapy Is Associated with a Reduced Risk of Atherosclerotic Cardiovascular Disease by Inhibiting Oxidative Stress and Cell Apoptosis in Diabetic Kidney Disease Patients.Jie-Sian Wang, Ping-Hsuan Tsai, Kuo-Feng Tseng
|Dec 23, 2022
Sesamol Attenuates Renal Inflammation and Arrests Reactive-Oxygen-Species-Mediated IL-1β Secretion via the HO-1-Induced Inhibition of the IKKα/NFκB Pathway In Vivo and In Vitro.Kuo-Feng Tseng, Ping-Hsuan Tsai, Jie-Sian Wang
|Apr 23, 2022
Apolipoprotein C3-Rich Low-Density Lipoprotein Induces Endothelial Cell Senescence via FBXO31 and Its Inhibition by Sesamol In Vitro and In Vivo.Ping-Hsuan Tsai, Li-Zhen Chen, Kuo-Feng Tseng
|Oct 23, 2021
Sesamol Ameliorates Renal Injury-Mediated Atherosclerosis via Inhibition of Oxidative Stress/IKKα/p53.Jie-Sian Wang, Ping-Hsuan Tsai, Kuo-Feng Tseng
|Oct 13, 2021
Kansuinine A Ameliorates Atherosclerosis and Human Aortic Endothelial Cell Apoptosis by Inhibiting Reactive Oxygen Species Production and Suppressing IKKβ/IκBα/NF-κB Signaling.Chen-Sheng Chen, Bo-Yi Pan, Ping-Hsuan Tsai
|Apr 03, 2021
IL-8 as a Potential Therapeutic Target for Periodontitis and Its Inhibition by Caffeic Acid Phenethyl Ester In Vitro.Yung-Kai Huang, Kuo-Feng Tseng, Ping-Hsuan Tsai
Pageof 1
